A carregar...
Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use
Oral antiplatelet drugs are crucially important for patients with acute coronary syndrome or stable coronary artery disease undergoing percutaneous coronary intervention (PCI). In recent decades, several clinical trials have focused on reducing periprocedural ischemic events in patients undergoing P...
Na minha lista:
| Publicado no: | Ther Adv Cardiovasc Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6906352/ https://ncbi.nlm.nih.gov/pubmed/31823688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944719893274 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|